Al-Dawaa, a pharmaceutical retail firm in Saudi Arabia, has set the price range for its initial public offering at SR65 ($17.3) to SR73 per share.
The company earlier announced it was offering 25.5 million shares in an IPO, or 30 percent of its capital of SR850 million through a sale by existing shareholders.
Institutional subscription has also started on Sunday, where they are initially allocated 100 percent of the offering, but could go down to 90 percent, Al-Dawaa said in a statement.
By signing up you agree to our Terms of Use and Privacy Policy
ABU DHABI, UAE – The Environment Agency – Abu Dhabi (EAD) has issued a policy on sustaining marine water quality that reviews the current situation and main challenges related to…
Abu Dhabi, UAE — Researchers at NYU Abu Dhabi (NYUAD) have developed an ingestible device that uses light to activate neurons in the gut. This new technology, called ICOPS (Ingestible…
GCC-listed companies' net profit dropped to US$ 57.9 billion in Q2-2023. While retail, capital goods, and utilities sectors faced profit declines, the banking sector thrived.
Rising security concerns, confrontational geopolitics, and chaotic global changes have fueled the demand for private military companies, the new reality of modern warfare.
In recent years, wellness travel has evolved from a niche pursuit to one of the most dynamic sectors in global tourism. What began as an occasional escape from stress has…
